Extracellular Vesicles from Mesenchymal Stem Cells: Potential as Therapeutics in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Xue Zou, David Brigstock, Nuria Morral · 2024
Read Extracellular Vesicles from Mesenchymal Stem Cells: Potential as Therapeutics in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by Xue Zou, David Brigstock, Nuria Morral (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11673942.txt.
Description
Fatty liver disease tied to metabolic problems can harden into inflammation, scarring, cirrhosis, and cancer. This review asks whether tiny parcels released by mesenchymal stem cells could treat it. These parcels, called extracellular vesicles, carry proteins and small RNA pieces from the stem cells that made them, and they can be given without transplanting the cells themselves.
Surveying lab and animal studies, the reviewers find the vesicles counter several drivers of the disease. They ease oxidative stress, reduce fat buildup and inflammation in the liver, and in a few studies slowed scarring. Some benefits trace to specific cargo molecules inside the vesicles. The authors say the approach is promising but unproven in patients, and that delivery methods and cargo selection need more work before trials can succeed.
Catalog record
| CREATOR | Xue Zou, David Brigstock, Nuria Morral |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |